"Quit on the Go" (formerly "Learn to Quit") for Tobacco Use Disorder
This trial will compare the effectiveness of a new app, Quit on the Go, to a standard of care smoking cessation intervention for people with serious mental illness.
- Tobacco Use Disorder
- Bipolar Disorder
- Mental Health Disorders
- Schizoaffective Disorder
- Major Depressive Disorder
- Persistent Depressive Disorder
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there any available spots for participants in this research experiment?
"This clinical trial is currently in search of participants, and its information on clinicialtrials.gov was initially posted on September 21st 2021 before being modified most recently on October 3rd 2022."
Is there a predetermined limit to the number of participants accepted into this clinical investigation?
"Correct. Clinicaltrials.gov data reveals that this clinical trial, published on September 21st 2021, is actively searching for 450 participants from 1 site."
Has the Learn to Quit App been used in any prior studies?
"Presently, 71 clinical trials are underway for the Learn to Quit App. Of those studies 5 have progressed to Phase 3 of research. Although Green Bay Wisconsin is where many of these experiments originate from, there exist 204 sites across America running tests on this treatment regimen."